Author: Jawdah Hannad Basara

The majority of the harm was caused by the picture. It appeared in the late summer of 2025, taken at some point during the Madden production in Atlanta. It featured a thick-necked man wearing a windbreaker with sagging jowls and a squint that only John Madden could have. Nicolas Cage was mentioned in the caption. To be sure, most people scrolled twice. The figure—fifty pounds—appeared in a matter of days. As actors are still expected to do when a role requires a body they don’t have, Cage is said to have eaten his way into the part. It’s a compelling…

Enter her name into a search bar and see what results the autocomplete provides. There is a sentence about her weight somewhere in that dropdown, usually close to the top. Since 2020, it has existed in some capacity, updated by Instagram screenshots, TikTok compilations, and thumbnail farms that view a young woman’s body as a replenishable resource. It’s odd how little of that traffic actually relates to what Charli D’Amelio has said. It began in earnest when she was fifteen. A few days before turning sixteen, in late April 2020, she sent a succinct, direct message on Twitter urging people…

August 25th did not arrive at Starbucks quietly, as it usually does. By the middle of the morning, the green-aproned baristas at locations all over the nation were handling a familiar surge—the kind that occurs once a year when a particular orange-tinted drink reappears on the menu board. The Pumpkin Spice Latte has returned. Even though it has been returning every fall for over 20 years, people still line up as if it might not happen again. However, the PSL is essentially irrelevant this year. With six new drinks joining a returning cast of seasonal favorites, the Starbucks fall menu…

At Starbucks, something changes every September. The menu boards fill with orange and amber, the green-and-white storefronts take on a slightly warmer hue, and a very specific set of drinks reappears—drinks that taste like a dessert someone decided to carbonate and smell like a scented candle. Among those beverages is the Iced Pumpkin Cream Shaken Espresso. It has a devoted fan base, a dedicated section on social media, and a calorie count that some people find unsettling, hidden in the Starbucks app’s nutrition section. The typical 16-ounce size that most people order is called a Grande, and it contains 310…

There is something almost theatrical about the way Dunkin’ does its freebies. No slow announcement, no long countdown. Just a code, a clock, and a million drinks waiting to disappear. Today, August 25, 2026, the chain is doing exactly that — dropping a free espresso beverage offer that, if you’re reading this at the right hour, you might still be able to grab. The code is EASYCHOICE. It went live at noon ET, and Dunkin’ is capping it at one million redemptions. That number sounds enormous until you remember this is a country that runs on coffee and moves fast…

A medication recall where the drug isn’t contaminated or inert but is just too potent is particularly unsettling. For thousands of Americans, Vitruvias Therapeutics, an Auburn, Alabama-based pharmaceutical company, is currently prescribing thyroid tablets. After testing revealed that the product might be superpotent, the company voluntarily recalled one lot of its 30 mg Thyroid Tablets, USP, on August 21, 2026. The news was met with a particular kind of dread for patients who depend on these tablets daily simply to feel functional. The impacted batch, Lot 504950, with NDC 69680-166-00 and an expiration date of September 30, 2026, was shipped…

ColonBroom will eventually locate you if you venture into any area of the internet related to wellness. The strawberry-flavored powder photo appears tidy and approachable against whatever pastel background the marketing team selected that week; the advertisements are polished, and the before-and-after testimonials are persuasive in that specific way that makes you want to believe them. According to the company’s own statistics, the product has helped over 500,000 people and has amassed a sizable following. It also consistently sells enough on Amazon to earn a bestseller badge in its category. All of this is intriguing because the fundamental component of…

Jorja Smith was sitting across from a journalist at a pub that had unintentionally turned into a wake on a hot July afternoon in southwest London. She was drinking an alcohol-free sparkling wine that she obviously found disappointing, and she was laughing between glances around the room. She appeared to be in good health. Excellent—loose, humorous, and in the moment. She was back on the road, her third album was about to be released, and the music she’d created with London producer P2J was genuinely exciting—a complete shift into UK garage and Afrobeats that felt more like someone finally putting…

The online discussion took exactly the expected turn when people began to notice that Tyler Henry appeared different. Comments accumulated. Screenshots went viral. The conjecture strayed into the customary cruel territory reserved on the internet for public figures whose bodies undergo noticeable physical changes. The fact that Henry had undergone several brain surgeries is something that the majority of people perusing those comment threads were unaware of or didn’t care to learn. It wasn’t a lifestyle issue that caused the weight gain. It had to do with medicine. Born in Hanford, California, on January 13, 1996, Henry became well-known thanks…

A molecule that has been mostly disregarded since the Nixon administration recently received a second look in a Berkeley lab, and the preliminary findings are making metabolic researchers take notice. Since the 1970s, biochemists have recognized TOFA, short for 5-tetradecyloxy-2-furoic acid, as an ACC inhibitor, a class of molecules that prevent the body from producing fats like triglycerides and cholesterol. Once, the category showed promise. The majority of ACC inhibitors ended up raising triglyceride levels, which is precisely the wrong direction for a medication intended to treat metabolic disease, after a series of clinical trials ran into the same brick…